awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47582466-A4A5DD18-58F8-4E74-8A99-E90508104D95
Q47582466-A4A5DD18-58F8-4E74-8A99-E90508104D95
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47582466-A4A5DD18-58F8-4E74-8A99-E90508104D95
Adherence and outcomes: a systematic review of palivizumab utilization.
P2860
Q47582466-A4A5DD18-58F8-4E74-8A99-E90508104D95
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47582466-A4A5DD18-58F8-4E74-8A99-E90508104D95
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
abeff2394d2350e18b3276e6d962c7be3b1bf669
P2860
A novel six consecutive monthly doses of palivizumab prophylaxis protocol for the prevention of respiratory syncytial virus infection in high-risk preterm infants in Taiwan.